Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1393537 | 0.98 | FAAH (0.47) | FAAHTDP1MEN1KMT2AZDHHC7 | |
| SCHEMBL1393272 | 0.98 | FAAH (0.47) | FAAHTDP1MEN1KMT2AZDHHC7 | |
| SCHEMBL11358682 | 0.98 | FAAH (0.47) | FAAHTDP1MEN1KMT2AZDHHC7 | |
| SCHEMBL4904972 | 0.98 | FAAH (0.47) | FAAHTDP1MEN1KMT2AZDHHC7 | |
| SCHEMBL6309982 | 0.98 | FAAH (0.47) | FAAHTDP1MEN1KMT2AZDHHC7 | |
| SCHEMBL873537 | 0.98 | FAAH (0.47) | FAAHTDP1MEN1KMT2AZDHHC7 | |
| SCHEMBL486944 | 0.98 | FAAH (0.47) | FAAHTDP1MEN1KMT2AZDHHC7 | |
| SCHEMBL28280400 | 0.96 | FAAH (0.46) | FAAHTDP1MEN1KMT2AZDHHC7 | |
| SCHEMBL650590 | 0.94 | TDP1 (0.45) | FAAHTDP1MEN1KMT2AL3MBTL1 | |
| SCHEMBL482827 | 0.92 | TDP1 (0.46) | FAAHTDP1MEN1KMT2AZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1151120-A1 | INDUCIBLE EXPRESSION SYSTEM FOR USE IN PLANTS | Syngenta Limited (GB) | 2001-11-07 | — | — | EP | claimed |
| WO-2000044917-A1 | INDUCIBLE EXPRESSION SYSTEM FOR USE IN PLANTS | SYNGENTA LIMITED (GB) | 2000-08-03 | — | — | WO | claimed |
| EP-0180745-A1 | Acylacetate and amidine intermediates for pyrimidone compounds, and their preparation | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1986-05-14 | — | — | EP | claimed |
| US-20230210808-A1 | 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS | CYMABAY THERAPEUTICS, INC. | 2023-07-06 | — | — | US | disclosed |
| EP-2876671-B1 | COMPOSITION FOR FORMING PASSIVATION LAYER, SEMICONDUCTOR SUBSTRATE HAVING PASSIVATION LAYER, METHOD OF PRODUCING SEMICONDUCTOR SUBSTRATE HAVING PASSIVATION LAYER, PHOTOVOLTAIC CELL ELEMENT, AND PHOTOVOLTAIC CELL | HITACHI CHEMICAL CO LTD (JP) | 2017-11-22 | — | — | EP | disclosed |
| US-20170304254-A1 | 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS | JANSSEN PHARMACEUTICA NV (DE) | 2017-10-26 | — | — | US | disclosed |
| US-9724322-B2 | 4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs | JANSSEN PHARMACEUTICA N.V. (BE) | 2017-08-08 | — | — | US | disclosed |
| US-9714262-B2 | Composition for forming passivation layer, semiconductor substrate having passivation layer, method of producing semiconductor substrate having passivation layer, photovoltaic cell element, method of producing photovoltaic cell element and photovoltaic cell | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2017-07-25 | — | — | US | disclosed |
| US-20160211389-A1 | COMPOSITION FOR FORMING PASSIVATION LAYER, SEMICONDUCTOR SUBSTRATE HAVING PASSIVATION LAYER, METHOD OF PRODUCING SEMICONDUCTOR SUBSTRATE HAVING PASSIVATION LAYER, PHOTOV OLTAIC CELL ELEMENT, METHOD OF PRODUCING PHOTOVOLTAIC CELL ELEMENT, AND PHOTOVOLTAIC CELL | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2016-07-21 | — | — | US | disclosed |
| US-20160199342-A1 | 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS | CYMABAY THERAPEUTICS, INC. | 2016-07-14 | — | — | US | disclosed |
| US-20150303317-A1 | SEMICONDUCTOR SUBSTRATE PROVIDED WITH PASSIVATION FILM AND PRODUCTION METHOD, AND PHOTOVOLTAIC CELL ELEMENT AND PRODUCTION METHOD THEREFOR | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2015-10-22 | — | — | US | disclosed |
| EP-0937703-A1 | METHOD FOR PURIFYING PYRUVIC ACID COMPOUNDS | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1999-08-25 | — | — | EP | disclosed |
| WO-1996006061-A2 | LATERALLY SUBSTITUTED CHLOROARENES, THEIR MANUFACTURE AND MIXTURES CONTAINING THEM | WOJSKOWA AKADEMIA TECHNICZNA (PL) | 1996-02-29 | — | — | WO | disclosed |
| US-4584384-A | HISTAMINE H2-ANTAGONISTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1986-04-22 | — | — | US | disclosed |
| US-4482563-A | HISTAMINE H2-ANTAGONIST | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1984-11-13 | — | — | US | disclosed |
| US-4407808-A | 2-Heterocyclic alkylamino-3-nitropyrroles | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1983-10-04 | — | — | US | disclosed |
| EP-0005985-B1 | 3-NITRO PYRROLE COMPOUNDS, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1983-04-27 | — | — | EP | disclosed |
| US-4331668-A | ANTIHISTAMINE, ANTAGONIST | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1982-05-25 | — | — | US | disclosed |
| US-4238494-A | HISTAMINE H2-RECEPTOR ANTAGONIST | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1980-12-09 | — | — | US | disclosed |
| EP-0005985-A1 | 3-Nitro pyrrole compounds, processes for preparing them and pharmaceutical compositions containing them | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230210808-A1 | 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS | PPARA, PPARG, PPARD | FAAH 1207/4885TDP1 3631/4885MEN1 4877/4885 |
| US-20170304254-A1 | 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS | PPARA, PPARG, PPARD | FAAH 1207/4885TDP1 3631/4885MEN1 4877/4885 |
| US-20160199342-A1 | 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS | PPARA, PPARG, PPARD | FAAH 1207/4885TDP1 3631/4885MEN1 4877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.